Literature DB >> 9367689

Identification of quantitative trait loci controlling levels of radiation-induced thymocyte apoptosis in mice.

M M Weil1, X Xia, Y Lin, L C Stephens, C I Amos.   

Abstract

Thymocyte apoptosis levels are higher in C57BL/6J mice than in C3Hf/Kam mice. Low-dose irradiation increases the numbers of thymocytes undergoing apoptosis, but the strain difference persists. We mapped three loci controlling radiation-induced thymocyte apoptosis levels in F2 intercross progeny of these strains. The strongest association of a genomic region with an apoptosis level occurred in a region of chromosome 11 known to harbor a locus (or loci) important in the pathogenesis of several rodent models of autoimmune disease. Additional loci influencing radiation-induced thymocyte apoptosis were identified on chromosomes 9 and 16. The genetic polymorphisms underlying these loci may have an evolutionary role in fine-tuning the apoptotic response in T cells and may be important in the etiology of lymphoproliferative disorders and autoimmunity. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367689     DOI: 10.1006/geno.1997.4999

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  2 in total

1.  Genetic mapping of loci controlling diethylstilbestrol-induced thymic atrophy in the Brown Norway rat.

Authors:  Karen A Gould; Tracy E Strecker; Kimberly K Hansen; Kimberly K Bynoté; Kelli A Peterson; James D Shull
Journal:  Mamm Genome       Date:  2006-05       Impact factor: 2.957

2.  Genetic modifiers regulating DNA replication and double-strand break repair are associated with differences in mammary tumors in mouse models of Li-Fraumeni syndrome.

Authors:  Prabin Dhangada Majhi; Nicholas B Griner; Jacob A Mayfield; Shannon Compton; Jeffrey J Kane; Trevor A Baptiste; Karen A Dunphy; Amy L Roberts; Sallie S Schneider; Evan M Savage; Divyen Patel; Anneke C Blackburn; Kim Joana Maurus; Lisa Wiesmüller; D Joseph Jerry
Journal:  Oncogene       Date:  2021-06-28       Impact factor: 9.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.